{"id":"https://openalex.org/W130968952","doi":null,"title":"Oral iloprost in healthy volunteers.","display_name":"Oral iloprost in healthy volunteers.","publication_year":1991,"publication_date":"1991-01-01","ids":{"openalex":"https://openalex.org/W130968952","mag":"130968952","pmid":"https://pubmed.ncbi.nlm.nih.gov/1722988"},"language":"en","primary_location":{"id":"pmid:1722988","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1722988","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eicosanoids","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042789080","display_name":"Michael S. Hildebrand","orcid":"https://orcid.org/0000-0003-2739-0515","observed_orcids":["https://orcid.org/0000-0003-2739-0515"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Hildebrand","raw_affiliation_strings":["Research Laboratories, Schering AG, Berlin, Federal Republic of Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Schering AG, Berlin, Federal Republic of Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113572249","display_name":"M Pfeffer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Pfeffer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032036068","display_name":"Marianne Mahler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Mahler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091887002","display_name":"Thomas Staks","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Staks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038254234","display_name":"F Windt-Hanke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Windt-Hanke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"A Sch\u00fctt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Sch\u00fctt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4068,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.74440518,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"4","issue":"3","first_page":"149","last_page":"54"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.7124000191688538,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.7124000191688538,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0738999992609024,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.05400000140070915,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/iloprost","display_name":"iloprost","score":1.0},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.7839999794960022},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8450000286102295},{"id":"https://openalex.org/keywords/dissolution-profile","display_name":"dissolution profile","score":0.5609999895095825},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.9860000014305115},{"id":"https://openalex.org/keywords/peripheral-vascular-disease","display_name":"peripheral vascular disease","score":0.6370000243186951},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.6380000114440918},{"id":"https://openalex.org/keywords/headache","display_name":"headache","score":0.35199999809265137},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C2781103887","wikidata":"https://www.wikidata.org/wiki/Q20817139","display_name":"Iloprost","level":3,"score":0.8393551111221313},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7316237092018127},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.6612370610237122},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.609724760055542},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.584909200668335},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5812726616859436},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.541724681854248},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4923824071884155},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.43290114402770996},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.42103683948516846},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34831365942955017},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1700754463672638},{"id":"https://openalex.org/C2781128415","wikidata":"https://www.wikidata.org/wiki/Q412050","display_name":"Prostacyclin","level":2,"score":0.15040266513824463},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016285","descriptor_name":"Iloprost","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016285","descriptor_name":"Iloprost","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:1722988","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1722988","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eicosanoids","raw_type":"Journal Article"},{"id":"mag:130968952","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1722988","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1986700243","https://openalex.org/W2069696124","https://openalex.org/W2085200339","https://openalex.org/W2126530260","https://openalex.org/W2906432632","https://openalex.org/W2090453324","https://openalex.org/W2019319952","https://openalex.org/W2124529161","https://openalex.org/W7166591697","https://openalex.org/W2008757484"],"abstract_inverted_index":{"Iloprost":[0],"is":[1],"a":[2,41,112,187],"potent":[3],"chemically":[4],"stable":[5],"PGI2-mimetic.":[6],"Therapeutic":[7],"efficacy":[8],"was":[9,130,146,167],"shown":[10],"after":[11,180],"i.v.":[12,181],"infusion":[13,182],"treatment":[14],"in":[15,37,54,102,114,125],"several":[16],"states":[17],"of":[18,40,62,66,77,89,117,119,139],"peripheral":[19],"vascular":[20],"disease.":[21],"For":[22],"out-patient":[23],"therapy":[24],"an":[25],"oral":[26,137],"dosage":[27,189],"form":[28],"should":[29],"be":[30],"developed.":[31],"Based":[32],"upon":[33],"dissolution":[34,116],"profiles":[35,177],"and":[36,83,148],"vivo":[38],"data":[39],"pig":[42],"model,":[43],"three":[44,67],"different":[45],"film-coated":[46],"pellet":[47],"formulations":[48,93],"were":[49,70,160],"selected":[50],"for":[51,153,162,169,183],"pharmacokinetic":[52,134],"characterization":[53,101],"nine":[55],"healthy":[56],"volunteers.":[57],"In":[58],"the":[59,63,87,120,133,142],"first":[60],"part":[61],"study":[64],"groups":[65],"test":[68,104],"subjects":[69,105],"treated":[71],"with":[72,186],"increasing":[73],"dosages":[74],"(150-300":[75],"micrograms)":[76],"iloprost.":[78],"At":[79],"300":[80],"micrograms":[81],"flush":[82],"headache":[84],"led":[85],"to":[86,172],"discontinuation":[88],"those":[90],"titration.":[91],"All":[92],"exhibited":[94,111],"dose-dependent":[95],"serum":[96,150,158,175],"level":[97,176],"profiles.":[98],"The":[99],"cross-over":[100],"all":[103],"showed":[106],"that":[107],"one":[108],"formulation,":[109],"which":[110],"modified":[113],"vitro":[115],"60%":[118],"dose":[121,144],"within":[122],"1":[123],"h":[124,155,185],"pH":[126],"7.4":[127],"phosphate":[128],"buffer,":[129],"optimal":[131],"from":[132],"profile.":[135],"After":[136],"administration":[138],"this":[140],"formulation":[141,166],"bioavailable":[143],"fraction":[145],"highest":[147],"half-maximal":[149],"levels":[151,159],"lasted":[152],"2.4":[154],"(mean);":[156],"therapeutic":[157,174],"maintained":[161],"2.1-5.0":[163],"h.":[164],"This":[165],"chosen":[168],"further":[170],"investigation":[171],"imitate":[173],"as":[178],"obtained":[179],"4-6":[184],"once-a-day":[188],"form.":[190]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}